<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02487524</url>
  </required_header>
  <id_info>
    <org_study_id>149/13/03/00/14</org_study_id>
    <nct_id>NCT02487524</nct_id>
  </id_info>
  <brief_title>Biomarkers of Neuropathic Pain in Women Treated for Breast Cancer</brief_title>
  <official_title>Biomarkers of Neuropathic Pain in Women Treated for Breast Cancer</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Helsinki University Central Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>deCODE genetics</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Helsinki University Central Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Investigators aim to identify the key phenotypes (biological, psychological, genetic)
      involved in the transition from acute to chronic neuropathic pain (NP) by comparison of the
      neuropathic pain phenotypes and genomics of patients developing NP or not under similar nerve
      injury conditions. The cohort is part of a previous prospective study of 1000 patients
      operated for breast cancer of whom 350 have surgeon defined intercostobrachial nerve
      resection during operation with or without persistent pain and additional 50 patients with
      pain, but no nerve resection during operation. Patients fill in questionnaires and a detailed
      sensory examination, cognitive tests, and a cold water test with autonomic nervous system
      monitoring are performed during the research visit. A selected group of patients undergo
      quantitative sensory testing (QST).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This cohort is part of a previous prospective study of 1000 breast cancer operated women. Of
      these, there are 350 patients with surgeon defined intercostobrachial nerve resection during
      the operation. Part of the patients have pain, part of them are pain free. In addition the
      investigators plan to enroll 50 patients with pain, but no nerve resection during operation.

      The patients come for a clinical research visit. Beforehand they fill in questionnaires of
      medical history, pain, mood, temperament, quality of life, and sleeping. After informed
      consent the patients give a blood sample with prior 12 hour fasting. The investigators
      present a detailed sensory testing with body maps and patient pain drawings. The
      investigators perform a cold water test with autonomic nervous system monitoring and conduct
      a set of cognitive tests, part of them computer based. A selected group of patients undergo
      QST.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">October 28, 2014</start_date>
  <completion_date type="Anticipated">December 2020</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Composite factors related to the persistence of pain after nerve injury</measure>
    <time_frame>5 years</time_frame>
    <description>Study of associations between phenotypic and genotypic data. Phenotyping is assessed by detailed sensory testing, questionnaires related to pain (Brief Pain Inventory, Numeric Rating Scale), psychological factors (Pain Catastrophizing Scale, Hospital Anxiety and Depression Rating Scale), personality (Ten-item Personality Inventory) and quality of life (36-item Short Form Health Survey and Insomnia Severity Index). Additionally, cognitive tests, a cold water test with autonomic nervous function monitoring, and a blood sample. DNA will be isolated from blood samples and analyzed for genetic variants associated with new neuropathic pain phenotypes.</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">402</enrollment>
  <condition>Neuropathic Pain</condition>
  <condition>Breast Cancer</condition>
  <arm_group>
    <arm_group_label>Nerve resection with pain</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Questionnaires, cognitive tests, sensory examination, cold water test with autonomic nervous system monitoring. QST.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Nerve resection without pain</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Questionnaires, cognitive tests, sensory examination, cold water test with autonomic nervous system monitoring. QST.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>No nerve resection but pain</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Questionnaires, cognitive tests, sensory examination, cold water test with autonomic nervous system monitoring. QST.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Cold water test</intervention_name>
    <description>The patients immerse their hand into cold water for a maximum of 90 seconds and report their pain intensity every 15 seconds during the test.</description>
    <arm_group_label>Nerve resection with pain</arm_group_label>
    <arm_group_label>Nerve resection without pain</arm_group_label>
    <arm_group_label>No nerve resection but pain</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Autonomic nervous system monitoring</intervention_name>
    <description>The autonomic nervous system is monitored during the cold water test and 15 minutes thereafter.</description>
    <arm_group_label>Nerve resection with pain</arm_group_label>
    <arm_group_label>Nerve resection without pain</arm_group_label>
    <arm_group_label>No nerve resection but pain</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>QST</intervention_name>
    <description>Quantitative sensory testing.</description>
    <arm_group_label>Nerve resection with pain</arm_group_label>
    <arm_group_label>Nerve resection without pain</arm_group_label>
    <arm_group_label>No nerve resection but pain</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  belongs to the cohort of 1000 breast cancer operated women and has had nerve resection
             during the operation (with or without pain) or no nerve resection, but pain

          -  sufficient Finnish language skills

        Exclusion Criteria:

          -  age over 75 years

          -  living far away from study site
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Eija Kalso, MD, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Helsinki University Central Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Helsinki University Central Hospital</name>
      <address>
        <city>Helsinki</city>
        <state>HUS</state>
        <zip>00029</zip>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Finland</country>
  </location_countries>
  <reference>
    <citation>Kaunisto MA, Jokela R, Tallgren M, Kambur O, Tikkanen E, Tasmuth T, Sipilä R, Palotie A, Estlander AM, Leidenius M, Ripatti S, Kalso EA. Pain in 1,000 women treated for breast cancer: a prospective study of pain sensitivity and postoperative pain. Anesthesiology. 2013 Dec;119(6):1410-21. doi: 10.1097/ALN.0000000000000012.</citation>
    <PMID>24343286</PMID>
  </reference>
  <reference>
    <citation>Meretoja TJ, Leidenius MHK, Tasmuth T, Sipilä R, Kalso E. Pain at 12 months after surgery for breast cancer. JAMA. 2014 Jan 1;311(1):90-92. doi: 10.1001/jama.2013.278795. Erratum in: JAMA. 2017 Apr 25;317(16):1693.</citation>
    <PMID>24381969</PMID>
  </reference>
  <reference>
    <citation>Haanpää M, Attal N, Backonja M, Baron R, Bennett M, Bouhassira D, Cruccu G, Hansson P, Haythornthwaite JA, Iannetti GD, Jensen TS, Kauppila T, Nurmikko TJ, Rice AS, Rowbotham M, Serra J, Sommer C, Smith BH, Treede RD. NeuPSIG guidelines on neuropathic pain assessment. Pain. 2011 Jan;152(1):14-27. doi: 10.1016/j.pain.2010.07.031. Epub 2010 Sep 19. Review.</citation>
    <PMID>20851519</PMID>
  </reference>
  <reference>
    <citation>Finnerup NB, Attal N, Haroutounian S, McNicol E, Baron R, Dworkin RH, Gilron I, Haanpää M, Hansson P, Jensen TS, Kamerman PR, Lund K, Moore A, Raja SN, Rice AS, Rowbotham M, Sena E, Siddall P, Smith BH, Wallace M. Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis. Lancet Neurol. 2015 Feb;14(2):162-73. doi: 10.1016/S1474-4422(14)70251-0. Epub 2015 Jan 7. Review.</citation>
    <PMID>25575710</PMID>
  </reference>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 25, 2015</study_first_submitted>
  <study_first_submitted_qc>June 29, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 1, 2015</study_first_posted>
  <last_update_submitted>February 27, 2018</last_update_submitted>
  <last_update_submitted_qc>February 27, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 28, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Helsinki University Central Hospital</investigator_affiliation>
    <investigator_full_name>Hanna Harno</investigator_full_name>
    <investigator_title>MD, PhD</investigator_title>
  </responsible_party>
  <keyword>Neuropathic Pain</keyword>
  <keyword>Breast Cancer</keyword>
  <keyword>Post surgical</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Breast Neoplasms</mesh_term>
    <mesh_term>Neuralgia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

